Garcia L F, Arango A M, Henao J E, Arbelaez M
Centro de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.
Transplant Proc. 1988 Aug;20(4):715-9.
One-year graft survival of 54 first cadaveric kidney transplants that received immunosuppressive treatment with CsA was analyzed with respect to the number of random pretransplant blood transfusions and the HLA class 1 and class 2 matching. Overall graft survival at 1 year was 80.7%. Patients with 3 to 20 pretransplant transfusions had a survival of 93.7% compared with 66.7% in those with less than three or more than 20 transfusions. All kidneys transplanted with two or less HLA-A + B mismatches survived at 1 year. With three mismatched antigens survival was of 88.9%. This value was reduced to 66.7% for four incompatibilities. A similar situation was found for HLA-DR matching since all kidneys with full compatibility survived at 1 year compared with 90.9% and 66.7% for one and two mismatches, respectively. HLA-B and HLA-DR exhibited an additive effect since again all grafts with two or less mismatches survived, whereas in the group with three different antigens this figure was 90% and only 1 of the three kidneys with completely different antigens survived.
对54例接受环孢素免疫抑制治疗的首例尸体肾移植受者的1年移植肾存活率进行了分析,分析内容涉及移植前随机输血次数以及HLA Ⅰ类和Ⅱ类配型情况。1年时的总体移植肾存活率为80.7%。移植前输血3至20次的患者存活率为93.7%,而输血次数少于3次或多于20次的患者存活率为66.7%。所有移植时HLA-A + B错配数为2个或更少的肾脏1年时均存活。有3个错配抗原时,存活率为88.9%。4个不相容时,该值降至66.7%。HLA-DR配型情况也类似,因为所有完全相容的肾脏1年时均存活,而1个错配和2个错配时的存活率分别为90.9%和66.7%。HLA-B和HLA-DR表现出相加效应,因为同样所有错配数为2个或更少的移植物均存活,而在有3种不同抗原的组中,这一数字为90%,3个抗原完全不同的3个肾脏中只有1个存活。